Atlas Trials

Cardiac Allograft Vasculopathy Inhibition With Alirocumab

Clinical trial NCT03537742 · COMPLETED

Trial details

NCT number
NCT03537742
Sponsor
Stanford University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Vasculopathy
Start date
2019-05-13
Primary completion
2025-07-11
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.